How do you start long-acting, injectable buprenorphine (LAIB) for a patient with opioid use disorder?
Long-acting injectable buprenorphine (1st gen Sublocade; 2nd gen Brixadi) can improve medication adherence, treatment retention, quality of life, and treatment satisfaction for patients with OUD.


